GSL Biotech announced today that the company has released its first web-based molecular biology product, SnapGene Server, a tool for biotech companies and nonprofit organizations to render interactive DNA maps on their websites. The technology also allows website visitors to input data from a variety of common file formats, and to generate interactive, annotated maps directly within their browsers.
2020 ROADMAP for DIGITAL CONVERGENCE: Transforming scientific information into actionable insight.
The Paperless Lab Academy is the ideal learning platform, for those considering consolidating, integrating and simplifying laboratory data management systems. The PLA is recognized by Gartner as one of the best European Lab Automation events!
Autoscribe Informatics is showing the Environmental Sampling Management module for its Matrix Gemini LIMS (Laboratory Information Management System) for the first time at Lab Innovations 2016. This new module uniquely links sampling point locations, test results and corrective action plans in one easy to use graphical environment. This makes it perfect for the management of sampling of sanitary conditions in production and storage areas in food/beverage production and other industries.
Leading IT technological innovations such as Software as a cloud storage and Service (SaaS) have revolutionized the operation of modern labs. Biobanks, CROs and research labs are fast-moving towards cloud technology, owing to excessive pressures of meeting deadlines and complexities associated with IT infrastructure and support. Why is cloud becoming the best choice for every lab, planning a LIMS implementation? This white paper is for those biobanks, clinical research and food & beverage testing labs which are incognizant of the benefits of cloud computing for managing laboratory operations.
Join us at the 66th Annual Meeting of the American Society of Human Genetics. The 2016 edition will be held at the Vancouver Convention Center in Vancouver, Canada, between October 18-22. You can find us at booth #1432 of the Exhibit Hall Floor (plan).
IQPC North America is proud to present CRISPR, A New Era in Gene Editing. We recognize that there are many ground breaking technologies, techniques, and researches occurring that are driving advancements in 2016 and beyond. The CRISPR event takes a comprehensive approach to understand the latest advances in gene editing to enhance drug delivery and develop clinical therapies. The industry’s sharpest minds will speak from their personal experiences and extensive expertise by means of case studies and in-depth workshops to improve CRISPR target efficiency and specificity and look toward the ultimate goal of personalizing medicine.
This December 2016, join IQPC in a comprehensive discussion of the strategies used by both researchers and IT professionals alike in order to leverage laboratory informatics technologies to benefit data integration, compress the discovery-to-market timeline, bring a higher level of functionality to labs, and develop sleek and swift centralized solutions. Hear from big pharma and small within the bounds of the same conference-- presenting their key strategies in managing large volumes of information, swiftly implementing change on a macro and micro scale, and optimizing R&D capabilities to advance clinical research at a rapid pace.
Emerging technological innovations enabled by next generation sensors will define the landscape for the future commercialization of life changing products. The exponential growth of the global sensors market and the demand for next generation integrated systems is expected to reach $18 billion by 2018. CHI's international faculty of key industry and academic leaders will present the latest technological advancements of real-world applications within healthcare and emerging markets through our conference tracks, symposiums and tutorials.
http://www.worldpreclinicaleurope.com/
The World Preclinical Congress Europe is a key networking event bringing together a global audience involved in preclinical research. It features conferences and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery.
Cambridge Healthtech Institute's High-Content Analysis & 3D Screening Conference is in its 14th year. The event explores the next generation in high-content and phenotypic screening and takes it to the third dimension. The High-Content Analysis and Phenotypic Screening stream will focus on the latest advancements in HCA technologies and applications, including phenotypic and high-content screening of 3D models, HCS image analysis and modeling, screening in physiologically-relevant cellular models, and case studies and strategies for successful phenotypic drug discovery
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Over the last three years, participation at PEGS Europe has grown by more than 60%, and this year will be the largest ever
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
: Join us at the 66th Annual Meeting of the American Society of Human Genetics.
The 2016 edition will be held at the Vancouver Convention Center in Vancouver, Canada, between October 18-22. You can find us at booth #1432 of the Exhibit Hall Floor (plan).
Today Genohm, a laboratory management software company with offices in Lausanne, Switzerland, Ghent, Belgium and Durham, NC, USA and Interactive Biosoftware, a genomic variant interpretation software company with offices in Rouen, France announced that they are entering in a technology partnership and integration. The partnership and the SLims-Alamut integration will offer customers a comprehensive solution that enables the seamless management of any NGS workflow from sample management, raw data generation to variant interpretation and reporting.
New modern, intuitive solution for small to mid-market pharma and biotech companies leverages best-practice quality processes used by leading life sciences companies to accelerate deployment
Lonza will hold a free 60-minute webinar on 2 November 2016 titled “LIMS and MODA-EM™ Solution – A Comprehensive Solution for Pharmaceutical Manufacturing Quality Control.”
Integrated systems for NGS data management and analysis: Open issues and available solutions
This 2016 paper by Bianchi et al., published in Frontiers in Genetics, takes a closer look at the major issues concerning next-generations sequencing (NGS) technology. The group raises five main concerns than an NGS research group should be aware of before approaching NGS technologies and briefly states positives and negatives to the most current popular tools. The group concludes "[a]lthough larger groups with enough computational members may prefer to develop and maintain their own tailored frameworks, smaller laboratories would save resources and improve their results by adopting solutions developed by third parties," including open-source and cloud-based tools.
Click here to read full article.
Today Genohm, a laboratory management software company with offices in Lausanne, Switzerland, Ghent, Belgium and Durham, NC, USA and Interactive Biosoftware, a genomic variant interpretation software company with offices in Rouen, France announced that they are entering in a technology partnership and integration.
The partnership and the SLims-Alamut integration will offer customers a comprehensive solution that enables the seamless management of any NGS workflow from sample management, raw data generation to variant interpretation and reporting.
We are actively looking for a few speakers to fill a couple open slots for the LIMS session at NEMC 2017 (www.nemc.us). The cutoff for abstract submittal is January 31st, 2017
Every software validation that is part of a Quality Risk Management program should start with a formal, documented risk assessment of the Laboratory Informatics systems that is being validated.